AI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech’s Zabopegdutide in Phase 2 MASH Trial

SINGAPORE and SEOUL, South Korea, June 17, 2026 /PRNewswire/ — HistoIndex, a leader in AI-powered digital pathology solutions for fibrosis assessment, and D&D Pharmatech, today announced positive results from HistoIndex’s AI-based quantitative analysis of liver biopsy samples from the…

Healthcare Insights Desk

Welcome to the Healthcare Insights Desk at TheUnplanned.in, where we delve deep into the world of health and wellness. Our dedicated team of writers brings you authoritative articles, expert opinions, and insightful analyses on all facets of healthcare.


Discover more from The Unplanned

Subscribe to get the latest posts sent to your email.

Scroll to Top

Discover more from The Unplanned

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights